Levels of the Gaucher disease biomarker glucosylsphingosine (lyso-Gb1) can have different trajectories in people who aren’t actively receiving treatment, a study found. While most untreated patients showed relatively little change in lyso-Gb1 over time, more than one-third experienced increases in the biomarker, which weren’t always associated with immediate disease…
Adults with Gaucher disease type 1 may develop subtle signs of heart dysfunction long before they experience symptoms or show abnormalities on standard heart tests, according to a small new study from Turkey. The researchers found that an advanced heart imaging scan — an ultrasound technique called speckle-tracking echocardiography,…
There was a time when getting medical information required a lot more effort. If you had a question about a symptom, a test result, or something your doctor mentioned in passing, you either waited until your next appointment or spent hours searching through websites and forums, trying to piece together…
